Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.
- DOI
- 10.1089/cbr.2011.1072
- Published
- 2012 Mar
- Container
- Cancer biotherapy & radiopharmaceuticals
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/cbr.2011.1072,
title = {Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.},
author = {Becker S and Lepareur N and Cadeillan V and Ardisson V and Bayat S and Noiret N and Garin E},
year = {2012},
journal = {Cancer biotherapy \& radiopharmaceuticals},
doi = {10.1089/cbr.2011.1072},
url = {https://doi.org/10.1089/cbr.2011.1072}
}RIS
TY - JOUR TI - Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity. AU - Becker S AU - Lepareur N AU - Cadeillan V AU - Ardisson V AU - Bayat S AU - Noiret N AU - Garin E PY - 2012 JO - Cancer biotherapy & radiopharmaceuticals DO - 10.1089/cbr.2011.1072 UR - https://doi.org/10.1089/cbr.2011.1072 ER -
APA
S, B., N, L., V, C., V, A., S, B., N, N., & E, G. (2012). Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1089/cbr.2011.1072
Source records
- pubmed · retrieved 2026-09-26T16:46:36.353Z
- europe-pmc · retrieved 2026-09-26T16:46:36.365Z
- hal · retrieved 2026-09-26T16:46:36.381Z